Oklahoma § 56-1011.6 Disease management program.

Oklahoma Statutes

§ 56-1011.6 — Disease management program.

Oklahoma § 56-1011.6

Title 56Poor Persons

This text of Oklahoma § 56-1011.6 (Disease management program.) is published on Counsel Stack Legal Research, covering Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Okla. Stat. tit. 56, § 56-1011.6 (2026).

Text

A.The Oklahoma Health Care Authority shall develop a formal program for disease management to improve the quality of care and reduce the cost of care. The Authority is authorized to contract for the development of the program if contracting is more cost effective to the state than developing the program internally. The disease management program may utilize pharmacy services including, but not limited to, Medication Management Therapy. The program may include, but not be limited to, asthma, diabetes, chronic obstructive pulmonary disease, renal disease and/or congestive heart failure. The disease management program shall consist of: 1. Claims data analysis; 2. Population selection and targeting; 3. Intervention through educational tools for patients and providers and treatment guidelines

Free access — add to your briefcase to read the full text and ask questions with AI

A. The Oklahoma Health Care Authority shall develop a formal program for disease management to improve the quality of care and reduce the cost of care. The Authority is authorized to contract for the development of the program if contracting is more cost effective to the state than developing the program internally. The disease management program may utilize pharmacy services including, but not limited to, Medication Management Therapy. The program may include, but not be limited to, asthma, diabetes, chronic obstructive pulmonary disease, renal disease and/or congestive heart failure. The disease management program shall consist of: 1. Claims data analysis; 2. Population selection and targeting; 3. Intervention through educational tools for patients and providers and treatment guidelines for physicians; 4. Quality measurements of program structure, performance indicators, and outcome measures; and 5. Reporting of outcome measure data. B. The Oklahoma Health Care Authority shall evaluate and report findings to the Governor and the Legislature no later than eighteen (18) months after the start of the program.